secwatch.observer — SEC 8-K summary
======================================

Issuer:     Wellgistics Health, Inc. (WGRX)
CIK:        0002030763
Form:       8-K
Filed at:   2026-05-21T10:51:51+00:00
Accession:  0001493152-26-024723
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 2.03, 3.02, 3.03, 5.03, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Wellgistics Health enters binding term sheet for DelivMeds AI; announces 1-for-50 reverse stock split
--------------------------------------------------------------------------------

- Binding term sheet with Datavault AI (DVLT), Scilex (SCLX) and others to form DelivMeds AI; combined asset value expected $4B (subject to fairness opinion).
- Existing public stockholders projected to retain ~10.4% of common post-conversion; new parties to own ~89.6% via convertible preferred.
- Wellgistics to acquire QOLPOM biometric IP from EOS/SCLX, expand PharmacyChain license to HaaS, and acquire controlling stake in Tollo Health (Health Lives Here).
- 1-for-50 reverse stock split effective May 26, 2026 to regain Nasdaq minimum bid compliance; shares reduce from ~125.7M to ~2.5M.
- Note purchase agreement amended: principal increased to $1.5M with additional $200K funding; Gerald Commissiong appointed Interim Co-CEO.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2030763/000149315226024723/0001493152-26-024723-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2030763/000149315226024723/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-024723

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer